Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia

被引：5
|
作者：
Cafforio, Luciana [1 ]
Raponi, Sara [1 ]
Cappelli, Luca Vincenzo [1 ]
Ilari, Caterina [1 ]
Soscia, Roberta [1 ]
De Propris, Maria Stefania [1 ]
Mariglia, Paola [1 ]
Rigolin, Gian Matteo [2 ]
Bardi, Antonella [2 ]
Peragine, Nadia
Piciocchi, Alfonso [3 ]
Arena, Valentina [3 ]
Mauro, Francesca Romana [1 ]
Cuneo, Antonio
Guarini, Anna [4 ]
Foa, Robin [1 ]
Del Giudice, Ilaria [1 ]
机构：
[1] Sapienza Univ, Hematol Sect, Dept Translat & Precis Med, Rome, Italy
[2] Univ Ferrara, Azienda Osped Univ Arcispedale S Anna, Dept Med Sci, Hematol Sect, Ferrara, Italy
[3] GIMEMA Fdn, GIMEMA Data Ctr, Rome, Italy
[4] Sapienza Univ, Dept Mol Med, Rome, Italy
来源：
HAEMATOLOGICA | 2022年 / 107卷 / 01期
关键词：
CLINICAL IMPACT; RESISTANCE; MUTATIONS;
D O I：
10.3324/haematol.2020.263715
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：334 / 337
页数：4
相关论文
共 50 条
  • [1] IBRUTINIB TREATMENT DOESN'T INDUCE TP53 CLONAL EVOLUTION IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Cafforio, L.
    Cappelli, L. V.
    Del Giudice, I.
    Ilari, C.
    Raponi, S.
    De Propris, M. S.
    Mariglia, P.
    Piciocchi, A.
    Arena, V.
    Vignetti, M.
    Mauro, F. R.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA, 2019, 104 : 1 - 2
  • [2] TP53 Clonal and Subclonal Architecture in Chronic Lymphocytic Leukemia Patients Under Ibrutinib Treatment
    Del Giudice, Ilaria
    Cafforio, Luciana
    Cappelli, Luca Vincenzo
    Ilari, Caterina
    Raponi, Sara
    De Propris, Maria Stefania
    Mariglia, Paola
    Mauro, Francesca Romana
    Vignetti, Marco
    Guarini, Anna
    Foa, Robin
    BLOOD, 2018, 132
  • [3] Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations
    Ahn, Inhye E.
    Tian, Xin
    Wiestner, Adrian
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05): : 498 - 500
  • [4] TP53 CLONAL AND SUBCLONAL ARCHITECTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER IMMUNOCHEMOTHERAPY AND IBRUTINIB
    Cafforio, L.
    Cappelli, L. V.
    Del Giudice, I.
    Ilari, C.
    Raponi, S.
    Mariglia, P.
    De Propris, M. S.
    Filetti, M.
    Mauro, F. R.
    Foa, R.
    Guarini, A.
    HAEMATOLOGICA, 2018, 103 : S27 - S27
  • [5] TP53 Disruption in Chronic Lymphocytic Leukemia Under Ibrutinib: More is Worse?
    Bomben, Riccardo
    Zucchetto, Antonella
    Gentile, Massimo
    Gattei, Valter
    CLINICAL CANCER RESEARCH, 2021, 27 (16) : 4462 - 4464
  • [6] RELATIONSHIP BETWEEN THERAPY AND CLONAL EVOLUTION OF TP53 ABNORMALITIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Malcikova, J.
    Smardova, J.
    Kuglik, P.
    Brychtova, Y.
    Doubek, M.
    Kotaskova, J.
    Tichy, B.
    Pospisilova, S.
    Mayer, J.
    Trbusek, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 364 - 365
  • [7] Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutation
    Bracher, Susanne
    Fuhrmann, Irene
    Jeromin, Sabine
    Nadarajah, Niroshan
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    Stengel, Anna
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (12) : 12247 - 12252
  • [8] Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutation
    Susanne Bracher
    Irene Fuhrmann
    Sabine Jeromin
    Niroshan Nadarajah
    Wolfgang Kern
    Torsten Haferlach
    Claudia Haferlach
    Anna Stengel
    Molecular Biology Reports, 2022, 49 : 12247 - 12252
  • [9] Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia
    Bomben, Riccardo
    Rossi, Maria Francesca
    D'Agaro, Tiziana
    Bittolo, Tamara
    Zucchetto, Antonella
    Tissino, Erika
    Pozzo, Federico
    Vit, Filippo
    Bulian, Pietro
    Degan, Massimo
    Zaina, Eva
    Cattarossi, Ilaria
    Nanni, Paola
    Chivilo, Hillarj
    D'Arena, Giovanni Francesco
    Chiarenza, Annalisa
    Santinelli, Enrico
    Zaja, Francesco
    Pozzato, Gabriele
    Di Raimondo, Francesco
    Del Poeta, Giovanni
    Gattei, Valter
    BLOOD, 2018, 132
  • [10] Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia
    J Malcikova
    K Stano-Kozubik
    B Tichy
    B Kantorova
    S Pavlova
    N Tom
    L Radova
    J Smardova
    F Pardy
    M Doubek
    Y Brychtova
    M Mraz
    K Plevova
    E Diviskova
    A Oltova
    J Mayer
    S Pospisilova
    M Trbusek
    Leukemia, 2015, 29 : 877 - 885
12345